dc.contributorSpringer
dc.creatorMedina Rivero, Emilio
dc.creatorBalderas Hernández, Víctor Emmanuel
dc.creatorOrdoñez Acevedo, Leandro Gabriel
dc.creatorPaz Maldonado, Luz María Teresita
dc.creatorBarba de la Rosa, Ana Paulina
dc.creatorDe León Rodríguez, Antonio
dc.date2018-06-07T20:16:38Z
dc.date2018-06-07T20:16:38Z
dc.date2007-09
dc.date.accessioned2023-07-17T22:05:22Z
dc.date.available2023-07-17T22:05:22Z
dc.identifierMedina-Rivero, E., Balderas-Hernández, V.E., Ordoñez-Acevedo, L.G. et al. Biotechnol Lett (2007) 29: 1369. https://doi.org/10.1007/s10529-007-9395-5
dc.identifierhttp://hdl.handle.net/11627/3844
dc.identifierhttps://doi.org/10.1007/s10529-007-9395-5
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/7544363
dc.description"Production of periplasmic human interferon-γ (hINF-γ) and human interleukin-2 (hIL-2) by the Tat translocation pathway in Escherichia coli BL21-SI was evaluated. The expression was obtained using the pEMR vector which contains the Tat-dependent modified penicillin acylase signal peptide (mSPpac) driven by the T7 promoter. The mSPpac-hINF-γ was processed and the protein was transported to periplasm. Up to 30.1% of hINF-γ was found in the periplasmic soluble fraction, whereas only 15% of the mSPpac-hIL-2 was processed, but hIL-2 was not found in the periplasmic soluble fraction."
dc.formatapplication/pdf
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rightsAcceso Abierto
dc.subjectPeriplasm
dc.subjectSignal peptide
dc.subjectTat pathway
dc.subjectTherapeutic protein
dc.subjectCIENCIAS AGROPECUARIAS Y BIOTECNOLOGÍA
dc.titleModified penicillin acylase signal peptide allows the periplasmic production of soluble human interferon-γ but not of soluble human interleukin-2 by the Tat pathway in Escherichia coli
dc.typearticle


Este ítem pertenece a la siguiente institución